Pharm

Estrogen

search

Estrogen, Ethinyl Estradiol, Mestranol, Conjugated Estrogen

  1. Swollen or engorged Breast tenderness
  2. Water retention
  3. Irritability
  4. Headaches
  5. Visual disturbance
  6. Memory difficulty
  7. Sweet craving
  • Pharmacokinetics
  • Relative Potency
  1. Ethinyl Estradiol: 100
  2. Mestranol: 67
  • Precautions
  1. Mestranol is potentially a carcinogen (animal studies)
  2. MI, CVA, DVT, PE and Breast Cancer risk are all FDA Black box warnings
  1. Ethinyl Estradiol
    1. Hormone Replacement: 0.005 to 0.02 mg/day
    2. Oral Contraceptive: 0.03 to 0.10 mg/day
  2. Micronized estradiol (1-2 mg/day)
  3. Estradiol Cypionate (2-5 mg every 3-4 weeks)
  4. Estradiol valerate (2-20 mg every other week)
  5. Estropipate (1.25-2.5 mg/day)
  6. Conjugated Estrogen (e.g. Premarin, Enjuvia)
    1. Oral (0.3-1.25 mg/day)
    2. Injectable (0.2-2 mg/day)
    3. Transdermal
  7. Diethylstilbestrol (0.1-0.5 mg/day)
  8. Quinestrol (0.1-0.2 mg/week)
  9. Chlorotrianisene (12-25 mg/day)
  10. Methallenestril (3-9 mg/day)
  11. Esterified Estrogen (Menest): 0.3 to 1.25 mg/day
  • Preparations
  • Native Estrogen with Selective Actions in Tissues (NEST)
  1. Background
    1. Native Estrogen with Selective Actions in Tissues (NEST) are plant-derived Estrogens (Phytoestrogens)
    2. Low potency and therefore 1000-fold higher doses are required (measured in mg NOT mcg)
      1. Nextstellis contains 14.2 mg of Estetrol, while most OCPs contain 20-30 mcg Ethinyl Estradiol
  2. Estetrol (E4)
    1. Estetrol is a new plant-derived Estrogen (E4) formulation available in 2021 as component of Nextstellis OCP
    2. Carries same Estrogen-related effects and contraindications
  3. References
    1. (2021) Presc Lett 28(7): 38